Journal of Applied Pharmaceutical Science, Volume 5, Pages 007-012 , 01/11/2015

2, 4-Di-tert-butylphenol, the bioactive compound produced by Streptomyces sp. KB1

Kittisak Chawawisit, Phuangthip Bhoopong, Worrapong Phupong, Monthon Lertcanawanichakul

Abstract

Streptomyces sp. KB1(TISTR 2304), identified by 16S rDNA gene, was collected from the air sample at Ao-nang, Krabi province, Thailand and deposited in the GeneBank database (accession number KF939581.1). It could produce bioactive compounds and excrete into liquid culture medium within 4 days of incubation period at 30 °C, 200 rounds per minute in shaking incubator. Bioactive compounds in culture broth supernatant were extracted with 3-times of ethyl acetate (EA), evaporated by rotary evaporator at 45 °C under reduced pressure, purified by silica gel column chromatography and eluted by gradient solvent system of ethyl acetate: hexane at ratio of 1:9, 3:7, 4:6, 6:4 and 10:0, v/v. Eight pooled fractions were obtained, name PF1 - PF8, from basis of their TLC profile. Only PF4 displayed as purified active compound which showed anti-methicillin resistant Staphylococcus aureus (MRSA) activity. The PF4 was predicted as 2, 4-Di-tert-butylphenol (C<inf>14</inf>H<inf>22</inf>O) with molecular weight 206.2.

Document Type

Article

Source Type

Journal

Keywords

24-Di-tert-butylphenolAnti-methicillin resistant Staphylococcus aureus activityStreptomyces sp. KB1

ASJC Subject Area

Pharmacology, Toxicology and Pharmaceutics : Pharmacology, Toxicology and Pharmaceutics (all)Medicine : Medicine (miscellaneous)Health Professions : Pharmacy

Funding Agency

Higher Education Research Promotion


Bibliography


Chawawisit, K., Bhoopong, P., Phupong, W., & Lertcanawanichakul, M. (2015). 2, 4-Di-tert-butylphenol, the bioactive compound produced by Streptomyces sp. KB1. Journal of Applied Pharmaceutical Science, 5007-012. doi:10.7324/JAPS.2015.510.S2

Copy | Save